Active

OPNIPHAR

Switched

BE0892559653

Rechtspersoon Private limited company 2 establishments

Broekstraat 28, 9255 Buggenhout Detailhandel in farmaceutische producten

Active for

18 year, 11 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 627,366

▲ 15% vs 2024

Profit

Growing

€ 43,653

▲ 1418% vs 2024

Debts

Normal

€ 1.4 million

▼ 8% vs 2024

OPNIPHAR from Buggenhout, company number BE0892559653, closed financial year 2025 with a result of € 43,653 after tax. For that financial year OPNIPHAR recorded a gross margin of € 627,366 and equity of € 534,041. Compared with financial year 2024, the result moved from € -3,313 to € 43,653. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 31, 2026.

What happened at OPNIPHAR?

What happened at OPNIPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 43,653. Source: NBB ↗
  • Janpharma BV became a director. NBB
  • Rita Segers became a director. NBB
  • Hugo Heyvaert became a director. NBB
  • Bex Pharma BV became a director. NBB
  • BVU Consulting BV became a director. NBB
  • New establishment in Buggenhout. KBO
  • New establishment in Kapelle-op-den-Bos. KBO

In short

From € 213,526 profit in 2021 to € 43,653 profit in 2025.

Paid € 72,386 in corporate taxes since 2021.

Best year ever: 2021, with € 213,526 profit.

On average € 114,100 of value added per employee in 2025.

A new publication or filing at OPNIPHAR? We notify you, reason included.

Follow OPNIPHAR

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Rita Segers
Hugo Heyvaert
+1
OPNIPHAR

Behind OPNIPHAR are Janpharma BV, Rita Segers, Hugo Heyvaert, Bex Pharma BV and BVU Consulting BV.

See the full network in the app

Directors

According to the 2025 annual accounts

Janpharma BV

Bestuurder · represented by Jan Heyvaert

since 2023

Rita Segers

Bestuurder

since 2023

Hugo Heyvaert

Bestuurder

since 2023

Bex Pharma BV

Bestuurder · represented by Liesbet Heyvaert

since 2023

BVU Consulting BV

Bestuurder · represented by Brett Van Uytvanck

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Broekstraat 28

9255 Buggenhout

2.166.430.761

Paddegatstraat 59

1880 Kapelle-op-den-Bos

Active since 4 October 2007

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0892.559.653
VAT number
BE 0892.559.653
Registered office
Broekstraat 28, 9255 Buggenhout
Names & denominations
OPNIPHAR
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 October 2007
Peppol
Active · Active since 24 Nov 2023
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What is the enterprise number of OPNIPHAR?
The enterprise number of OPNIPHAR is BE0892559653.
What is the address of OPNIPHAR?
The registered office of OPNIPHAR is located at Broekstraat 28, 9255 Buggenhout.
When was OPNIPHAR founded?
OPNIPHAR was founded on 4 October 2007.
What is the main activity of OPNIPHAR?
The main activity of OPNIPHAR is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does OPNIPHAR have a website?
No website is currently known for OPNIPHAR.
How much profit did OPNIPHAR make in 2025?
OPNIPHAR posted a profit after taxes of € 43,653 in financial year 2025.
What is the revenue of OPNIPHAR?
As a small company, OPNIPHAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 627,366.
How many employees does OPNIPHAR have?
According to the 2025 annual accounts, OPNIPHAR has 5.5 full-time equivalents (FTE).
Where can I find the annual accounts of OPNIPHAR?
OPNIPHAR files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of OPNIPHAR?
According to the 2025 annual accounts, the directors of OPNIPHAR are: Janpharma BV, Rita Segers, Hugo Heyvaert, Bex Pharma BV, BVU Consulting BV.
Who owns OPNIPHAR?
Behind OPNIPHAR are Janpharma BV, Rita Segers, Hugo Heyvaert, Bex Pharma BV and BVU Consulting BV.